Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Celularity Inc. CELUW
$0.05
-$0.02 (-30.60%)
На 18:05, 12 мая 2023
Ранг: 2
Ключевые показатели
-
Marketcap
7024155.00000000
-
week52high
0.05
-
week52low
0.05
-
Revenue
17975000
-
P/E TTM
-594
-
Beta
0.20566900
-
EPS
-0.87000000
-
Last Dividend
0.00000000
-
Next Earnings Date
07 мая 2023 г. в 08:13
Описание компании
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-derived CAR-T therapy, which is in Phase I clinical trial for the treatment of B-cell malignancies; CYNK-001, placental-derived unmodified natural killer (NK) cell that is in Phase I clinical trial to treat acute myeloid leukemia, as well as in Phase I/IIa clinical trial for the treatment of glioblastoma multiforme and COVID-19; CYNK-101, an allogeneic genetically modified NK cell, which is in Phase I clinical trial to treat HER2+ gastric and gastroesophageal cancers; APPL-001, a placenta-derived mesenchymal-like adherent stromal cell that is in a pre-clinical stage for the treatment of Crohn's disease; and PDA-002, a placenta-derived mesenchymal-like adherent stromal cell, which is in pre-clinical stage for the treatment of facioscapulohumeral muscular dystrophy. It also sells and licenses products that are used in surgical and wound care markets, such as Biovance and Interfyl; collects stem cells from umbilical cords and placentas; and provides cells storage under the LifebankUSA brand. The company was incorporated in 2016 and is headquartered in Florham Park, New Jersey.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
Truist Securities | Hold | Buy | 06 апр 2022 г. |
Oppenheimer | Outperform | 28 янв 2022 г. | |
Morgan Stanley | Equal-Weight | 24 ноя 2021 г. | |
Truist Securities | Buy | 19 окт 2021 г. |
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
Hariri Robert J | A | 8074996 | 10000 | 30 ноя 2022 г. |
Hariri Robert J | A | 8064996 | 40000 | 29 ноя 2022 г. |
Hariri Robert J | A | 8024996 | 40000 | 28 ноя 2022 г. |
Fletcher Kyle | D | 34170 | 1262 | 16 ноя 2022 г. |
Jones Anne | D | 49154 | 3734 | 16 ноя 2022 г. |
Kilcoyne Adrian | A | 66226 | 66226 | 03 окт 2022 г. |
SCULLEY JOHN | D | 0 | 768594 | 26 авг 2022 г. |
SCULLEY JOHN | A | 804739 | 768594 | 26 авг 2022 г. |
Hariri Robert J | D | 230287 | 119073 | 24 авг 2022 г. |
Hariri Robert J | A | 7984996 | 119073 | 24 авг 2022 г. |
Свежие комментарии
Свежие комментарии